Correlation Between OncoVista Innovative and Xenon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both OncoVista Innovative and Xenon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoVista Innovative and Xenon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoVista Innovative Therapies and Xenon Pharmaceuticals, you can compare the effects of market volatilities on OncoVista Innovative and Xenon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoVista Innovative with a short position of Xenon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoVista Innovative and Xenon Pharmaceuticals.
Diversification Opportunities for OncoVista Innovative and Xenon Pharmaceuticals
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between OncoVista and Xenon is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding OncoVista Innovative Therapies and Xenon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xenon Pharmaceuticals and OncoVista Innovative is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoVista Innovative Therapies are associated (or correlated) with Xenon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xenon Pharmaceuticals has no effect on the direction of OncoVista Innovative i.e., OncoVista Innovative and Xenon Pharmaceuticals go up and down completely randomly.
Pair Corralation between OncoVista Innovative and Xenon Pharmaceuticals
Given the investment horizon of 90 days OncoVista Innovative Therapies is expected to generate 3.51 times more return on investment than Xenon Pharmaceuticals. However, OncoVista Innovative is 3.51 times more volatile than Xenon Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Xenon Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 0.01 in OncoVista Innovative Therapies on November 2, 2024 and sell it today you would earn a total of 0.01 from holding OncoVista Innovative Therapies or generate 100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.4% |
| Values | Daily Returns |
OncoVista Innovative Therapies vs. Xenon Pharmaceuticals
Performance |
| Timeline |
| OncoVista Innovative |
| Xenon Pharmaceuticals |
OncoVista Innovative and Xenon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OncoVista Innovative and Xenon Pharmaceuticals
The main advantage of trading using opposite OncoVista Innovative and Xenon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoVista Innovative position performs unexpectedly, Xenon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xenon Pharmaceuticals will offset losses from the drop in Xenon Pharmaceuticals' long position.| OncoVista Innovative vs. Cyclacel Pharmaceuticals | OncoVista Innovative vs. Amylyx Pharmaceuticals | OncoVista Innovative vs. Axsome Therapeutics | OncoVista Innovative vs. Exelixis |
| Xenon Pharmaceuticals vs. Nuvalent | Xenon Pharmaceuticals vs. Arcellx | Xenon Pharmaceuticals vs. Vaxcyte | Xenon Pharmaceuticals vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |